Tirzepatide 30mg

Two receptors, one mechanism

Tirzepatide activates GLP-1 and GIP receptors simultaneously, placing it among the newest generation of dual incretin agonists. This combination is central to current studies on metabolism and energy balance.

This 30 mg pack in the lab

The 30 mg pack covers larger protocols or several parallel experiment runs from a single batch. The dual mechanism makes Tirzepatide an important tool for studying glucose regulation and energy metabolism.

Example calculation: reconstitution

For a working concentration of 10 mg/ml, the 30 mg vial is reconstituted with 3 ml of sterile solvent (add slowly along the inner wall of the vial, then swirl gently — never shake). Step-by-step process: Application Guide.

Quality you can measure

Each batch is checked by HPLC for ≥98.9% purity, with a certificate of analysis included.

Other sizes: 10 mg 20 mg

Does purity stay the same across larger packs?

Yes — every batch is individually verified by HPLC to ≥98.9%, regardless of pack size.

For research purposes only. Not intended for human consumption.